• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p21WAF1/CIP1与蛋白激酶CK2相互作用。

p21WAF1/CIP1 interacts with protein kinase CK2.

作者信息

Götz C, Wagner P, Issinger O G, Montenarh M

机构信息

Institute of Medical Biochemistry, University of the Saarland, Homburg, Germany.

出版信息

Oncogene. 1996 Jul 18;13(2):391-8.

PMID:8710378
Abstract

p21WAF1/CIP1 which belongs to a class of regulatory proteins that interact with cyclin dependent kinases is a potent inhibitor of these kinases. The inhibition of the cyclin dependent kinases induces an arrest of cells in the G phase of the cell cycle. In addition p21WAF1/CIP1 associates with PCNA and inhibits DNA replication. Here, we show that p21WAF1/CIP1 binds to the regulatory beta-subunit of protein kinase CK2 but not to the catalytic alpha-subunit. Binding of p21WAF1/CIP1 down regulates the kinase activity of CK2 with respect to the phosphorylation of the beta-subunit of CK2, casein and the C-terminus of p53. This study demonstrates a new binding partner for the regulatory beta-subunit of protein kinase CK2 which regulates the activity of the holoenzyme.

摘要

属于与细胞周期蛋白依赖性激酶相互作用的一类调节蛋白的p21WAF1/CIP1是这些激酶的有效抑制剂。细胞周期蛋白依赖性激酶的抑制会导致细胞在细胞周期的G期停滞。此外,p21WAF1/CIP1与增殖细胞核抗原(PCNA)结合并抑制DNA复制。在此,我们表明p21WAF1/CIP1与蛋白激酶CK2的调节β亚基结合,但不与催化α亚基结合。p21WAF1/CIP1的结合下调了CK2对CK2β亚基、酪蛋白和p53 C末端磷酸化的激酶活性。这项研究证明了蛋白激酶CK2调节β亚基的一种新结合伴侣,该伴侣调节全酶的活性。

相似文献

1
p21WAF1/CIP1 interacts with protein kinase CK2.p21WAF1/CIP1与蛋白激酶CK2相互作用。
Oncogene. 1996 Jul 18;13(2):391-8.
2
Protein p21(WAF1/CIP1) is phosphorylated by protein kinase CK2 in vitro and interacts with the amino terminal end of the CK2 beta subunit.蛋白质p21(WAF1/CIP1)在体外被蛋白激酶CK2磷酸化,并与CK2β亚基的氨基末端相互作用。
J Cell Biochem. 2001;81(3):445-52. doi: 10.1002/1097-4644(20010601)81:3<445::aid-jcb1058>3.0.co;2-2.
3
The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.p53的羧基末端模拟了蛋白激酶CK2催化的MDM2磷酸化的多聚赖氨酸效应。
Oncogene. 1997 Jun 5;14(22):2683-8. doi: 10.1038/sj.onc.1201112.
4
F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.由于p21WAF1/CIP1降解,F9胚胎癌细胞在γ射线照射后无法在细胞周期的G1/S边界处停止。
Oncogene. 2000 Aug 10;19(34):3858-65. doi: 10.1038/sj.onc.1203736.
5
Binding domain for p21(WAF1) on the polypeptide chain of the protein kinase CK2 beta-subunit.蛋白激酶CK2β亚基多肽链上p21(WAF1)的结合结构域。
Biochem Biophys Res Commun. 2000 Feb 24;268(3):882-5. doi: 10.1006/bbrc.2000.2230.
6
p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.p21Waf1/Cip1/Sdi1在缺乏功能性p53的人类肿瘤细胞中诱导永久性生长停滞,并伴有复制性衰老的标志物。
Oncogene. 1999 May 6;18(18):2789-97. doi: 10.1038/sj.onc.1202615.
7
A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.一种DNA复制的小分子肽抑制剂确定了细胞周期蛋白依赖性激酶抑制剂p21WAF1与增殖细胞核抗原之间的相互作用位点。
Curr Biol. 1995 Mar 1;5(3):275-82. doi: 10.1016/s0960-9822(95)00058-3.
8
Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate.苯乙酸诱导人乳腺癌MCF-7细胞生长停滞过程中p21Waf1/Cip1的上调及其功能作用
Cell Growth Differ. 1996 Dec;7(12):1609-15.
9
Interactions of protein kinase CK2 subunits.蛋白激酶CK2亚基的相互作用。
Mol Cell Biochem. 1999 Jan;191(1-2):75-83.
10
IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1.γ干扰素对胶质母细胞瘤细胞生长的抑制作用与细胞周期蛋白依赖性激酶抑制剂p21WAF1/CIP1水平的升高相关。
Oncogene. 1998 Dec 10;17(23):2973-9. doi: 10.1038/sj.onc.1202217.

引用本文的文献

1
The Emerging Role of p21 in Diabetes and Related Metabolic Disorders.p21在糖尿病及相关代谢紊乱中的新作用
Int J Mol Sci. 2024 Dec 9;25(23):13209. doi: 10.3390/ijms252313209.
2
CK2 and the Hallmarks of Cancer.蛋白激酶CK2与癌症特征
Biomedicines. 2022 Aug 16;10(8):1987. doi: 10.3390/biomedicines10081987.
3
CK2 Regulation: Perspectives in 2021.CK2调控:2021年展望
Biomedicines. 2021 Sep 30;9(10):1361. doi: 10.3390/biomedicines9101361.
4
Thr55 phosphorylation of p21 by MPK38/MELK ameliorates defects in glucose, lipid, and energy metabolism in diet-induced obese mice.MPK38/MELK 介导的 p21 的 Thr55 磷酸化可改善饮食诱导肥胖小鼠在葡萄糖、脂质和能量代谢方面的缺陷。
Cell Death Dis. 2019 May 16;10(6):380. doi: 10.1038/s41419-019-1616-z.
5
Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model.核纤层蛋白 A 通过缓冲 CK2 激酶活性来调节早衰症小鼠模型的衰老。
Sci Adv. 2019 Mar 20;5(3):eaav5078. doi: 10.1126/sciadv.aav5078. eCollection 2019 Mar.
6
Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.蛋白激酶 CK2β亚基在小鼠卵母细胞中的缺失导致卵泡闭锁和卵巢早衰。
Cell Death Dis. 2018 May 1;9(5):508. doi: 10.1038/s41419-018-0505-1.
7
p21 and CK2 interaction-mediated HDAC2 phosphorylation modulates KLF4 acetylation to regulate bladder cancer cell proliferation.p21与CK2相互作用介导的HDAC2磷酸化调节KLF4乙酰化以调控膀胱癌细胞增殖。
Tumour Biol. 2016 Jun;37(6):8293-304. doi: 10.1007/s13277-015-4618-1. Epub 2016 Jan 4.
8
Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.联合表观遗传药物、DNMT 抑制剂 zebularine 和 RG108 与 HDAC 抑制剂对早幼粒细胞白血病 HL-60 细胞的抗白血病活性。
Cell Mol Biol Lett. 2012 Dec;17(4):501-25. doi: 10.2478/s11658-012-0024-5. Epub 2012 Jul 20.
9
Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1.酪蛋白激酶2和蛋白磷酸酶1对伊卡洛斯功能的调节
World J Biol Chem. 2011 Jun 26;2(6):126-31. doi: 10.4331/wjbc.v2.i6.126.
10
Ability of CK2beta to selectively regulate cellular protein kinases.CK2β选择性调节细胞蛋白激酶的能力。
Mol Cell Biochem. 2008 Sep;316(1-2):115-26. doi: 10.1007/s11010-008-9817-2. Epub 2008 Jun 17.